Revenue: The sum of all revenue fields included for a company's operating activities.
Pharming Group N.V. Sponsored ADR (PHAR) had Revenue of $245.32M for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
Revenue |
$245.32M |
$-10.55M |
|
$25.21M |
|
$220.10M |
|
$250.70M |
|
$-5.39M |
|
$-6.62M |
|
$-12.01M |
|
$-12.01M |
|
$-10.55M |
|
$-10.55M |
|
$-10.55M |
|
$-10.55M |
|
$-5.39M |
|
$10.54M |
|
65.70M |
|
72.55M |
|
$-0.16 |
|
$-0.16 |
|
Balance Sheet Financials | |
$316.34M |
|
$9.69M |
|
$146.51M |
|
$462.85M |
|
$77.97M |
|
$136.60M |
|
$166.10M |
|
$244.07M |
|
$218.78M |
|
$147.51M |
|
$218.78M |
|
67.11M |
|
Cash Flow Statement Financials | |
$-17.30M |
|
$-129.39M |
|
$-1.04M |
|
$207.34M |
|
$61.74M |
|
$-145.60M |
|
$9.25M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
4.06 |
|
-- |
|
-- |
|
0.38 |
|
0.63 |
|
89.72% |
|
-2.20% |
|
-2.20% |
|
4.30% |
|
-4.90% |
|
-4.30% |
|
$-18.74M |
|
-- |
|
-- |
|
-- |
|
0.53 |
|
0.44 |
|
5.31 |
|
68.68 |
|
-4.82% |
|
-7.15% |
|
-2.28% |
|
-2.97% |
|
$3.26 |
|
$-0.26 |
|
$-0.24 |